Overcoming Barriers to Clinical Trial Enrollment
- 1 May 2019
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Asco Educational Book
- No. 39,p. 105-114
- https://doi.org/10.1200/edbk_243729
Abstract
Clinical trials are imperative for testing novel cancer therapies, advancing the science of cancer care, and determining the best treatment strategies to enhance outcomes for patients with cancer. However, barriers to clinical trial enrollment contribute to low participation in cancer clinical trials. Many factors play a role in the persistently low rates of trial participation, including financial barriers, logistical concerns, and the lack of resources for patients and clinicians to support clinical trial enrollment and retention. Furthermore, restrictive eligibility criteria often result in the exclusion of certain patient populations, which thus adds to the widening disparities seen between patients who enroll in trials and those treated in routine practice. Moreover, additional factors, such as difficulty by patients and clinicians in coping with the uncertainty inherent to clinical trial participation, contribute to low trial enrollment and represent key components of the decision-making process. Specifically, patients and clinicians may struggle to assess the risk-benefit ratio and may incorrectly estimate the probability and severity of challenges associated with clinical trial participation, thus complicating the informed consent process. Importantly, research has increasingly focused on overcoming barriers to clinical trial enrollment. A promising solution involves the use of patient navigators to help enhance clinical trial recruitment, enrollment, and retention. Although clinical trials are essential for improving and prolonging the lives of patients with cancer, barriers exist that can impede trial enrollment; yet, efforts to recognize and address these barriers and enhance trial enrollment are being investigated.Keywords
This publication has 75 references indexed in Scilit:
- Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care ActJAMA Oncology, 2018
- Financial Burden in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2017
- Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With CancerJAMA Oncology, 2017
- Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal CancerJournal of Clinical Oncology, 2016
- Financial Insolvency as a Risk Factor for Early Mortality Among Patients With CancerJournal of Clinical Oncology, 2016
- Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity ProgramThe Oncologist, 2016
- Identifying cancer patients who alter care or lifestyle due to treatment‐related financial distressPsycho‐Oncology, 2015
- Economic Burden of Cancer Survivorship Among Adults in the United StatesJournal of Clinical Oncology, 2013
- Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer DiagnosisHealth Affairs, 2013
- The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's ExperienceThe Oncologist, 2013